This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Actelion Pharmaceuticals Ltd.
Drug Names(s): clazosentan, AVX-034343
Description: Clazosentan is a selective endotheline A receptor antagonist that prevents vasospasm.
Deal Structure: Clazosentan was licensed to Axovan from Roche in 2002, and Actelion acquired Axovan in 2003.
Partners: Roche Holding AG
Additional information available to subscribers only: